1. Home
  2. MRK

MRK

Merck & Company Inc. (new)

as 03-28-2025 4:00pm EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Founded: 2000 Country:
United States
United States
Employees: N/A City: KENILWORTH
Market Cap: N/A IPO Year: N/A
Target Price: $121.40 AVG Volume (30 days): 17.4M
Analyst Decision: Buy Number of Analysts: 16
Dividend Yield:
3.63%
Dividend Payout Frequency: Quarterly
EPS: 6.74 EPS Growth: 4714.29
52 Week Low/High: $81.04 - $134.63 Next Earning Date: 04-24-2025
Revenue: $64,168,000,000 Revenue Growth: 6.74%
Revenue Growth (this year): 2.59% Revenue Growth (next year): 6.47%

MRK Daily Stock ML Predictions

Stock Insider Trading Activity of Merck & Company Inc. (new) (MRK)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Downing Cristal N MRK Chief Comm. & Public Afrs Ofcr Feb 6 '25 Sell $88.76 2,361 $209,550.79 7,085
BAKER DOUGLAS M JR MRK Director Feb 5 '25 Buy $88.50 15,000 $1,327,500.00 16,000

Share on Social Networks: